Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease

A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video

(2018) Chuyan Long et al.   BMC GASTROENTEROLOGY

Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease

(2018) Alka Goyal et al.   INFLAMMATORY BOWEL DISEASES

Microbiota transplantation: concept, methodology and strategy for its modernization

(2018) Faming Zhang et al.   Protein & Cell

A microbial signature for Crohn's disease

(2017) Victoria Pascal et al.   GUT

Gut microbiota and IBD: causation or correlation?

(2017) Josephine Ni et al.   Nature Reviews Gastroenterology & Hepatology

Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass

(2017) Zhi He et al.   Scientific Reports

Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease

(2016) Byron P. Vaughn et al.   INFLAMMATORY BOWEL DISEASES

Clinical efficacy maintains patients’ positive attitudes toward fecal microbiota transplantation

(2016) Lijuan Xu et al.   MEDICINE

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation

(2015) Kaija-Leena Kolho et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome

(2015) D. Weber et al.   BLOOD

Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

(2015) Aze Wilson et al.   DIGESTIVE DISEASES AND SCIENCES

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

(2015) Paul Moayyedi et al.   GASTROENTEROLOGY

Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs Disease

(2015) David L. Suskind et al.   INFLAMMATORY BOWEL DISEASES

Urinary 1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

(2015) A Miccheli et al.   INTERNATIONAL JOURNAL OF OBESITY

Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis

(2015) Bota Cui et al.   Journal of Translational Medicine

Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis

(2015) J. Landy et al.   Scientific Reports

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

(2014) Dirk Gevers et al.   Cell Host & Microbe

Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis

(2014) Ruben J. Colman et al.   Journal of Crohns & Colitis

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results

(2014) Bota Cui et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases

(2014) Tomasz Dawiskiba   WORLD JOURNAL OF GASTROENTEROLOGY

Metabolomics

(2013) Martin Storr et al.   CURRENT OPINION IN GASTROENTEROLOGY

Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy

(2012) Natasha S. Stephens et al.   Journal of Crohns & Colitis

Decreased abundance ofFaecalibacterium prausnitziiin the gut microbiota of Crohn's disease

(2012) Takehide Fujimoto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Host-Gut Microbiota Metabolic Interactions

(2012) J. K. Nicholson et al.   SCIENCE

Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host

(2011) Jaclyn Strauss et al.   INFLAMMATORY BOWEL DISEASES

Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease

(2010) Horace RT Williams et al.   BMC GASTROENTEROLOGY

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA